| Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition. K Gainsford, B Fitzgibbon, PB Fitzgerald, KE Hoy Psychiatry research 288, 112974, 2020 | 40 | 2020 |
| Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial C Loo, N Glozier, D Barton, BT Baune, NT Mills, P Fitzgerald, P Glue, ... The British Journal of Psychiatry, 1-9, 2023 | 32 | 2023 |
| Investigating neurophysiological markers of impaired cognition in schizophrenia KE Hoy, H Coyle, K Gainsford, AT Hill, NW Bailey, PB Fitzgerald Schizophrenia Research 233, 34-43, 2021 | 14 | 2021 |
| No Consistent Antidepressant Effects of Deep Brain Stimulation of the Bed Nucleus of the Stria Terminalis PB Fitzgerald, K Hoy, KE Richardson, K Gainsford, R Segrave, SE Herring, ... Brain Sciences 14 (5), 499, 2024 | 1 | 2024 |
| Investigating neurophysiological effects of a short course of tDCS for cognition in schizophrenia: a target engagement study KE Hoy, H Coyle, K Gainsford, AT Hill, NW Bailey, PB Fitzgerald medRxiv, 2022.03. 02.22271807, 2022 | 1 | 2022 |
| Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression-The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial C Loo, N Glozier, D Barton, B Baune, N Mills, PB Fitzgerald, P Glue, ... | | |
